Tocqueville Asset Management L.P. Bio Techne Corp Transaction History

Tocqueville Asset Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $2,581 - $3,597	-8 Reduced 0.66%	1,200 $416,000
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $1,769 - $2,438	-5 Reduced 0.41%	1,208 $523,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $2,280 - $2,625	-5 Reduced 0.41%	1,213 $628,000
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $5,422 - $6,303	-14 Reduced 1.14%	1,218 $548,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $1,258 - $1,644	-4 Reduced 0.32%	1,232 $471,000
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $740 - $965	-3 Reduced 0.24%	1,236 $392,000
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $6,966 - $8,488	30 Added 2.48%	1,239 $307,000
Q2 2020 Aug 12, 2020	BUY	$185.43 - $279.56 $1,668 - $2,516	9 Added 0.75%	1,209 $319,000
Q4 2019 Jan 14, 2020	BUY	$189.68 - $222.09 $227,616 - $266,508	1,200 New	1,200 $263,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.